Toby, the diagnostic startup named after Sherlock Holmes's bloodhound, has created a single urine test for multiple cancer detection.
Current Status
Currently going through a final validation study with The Duke Cancer Institute.
Problem or Opportunity
This year 35,000 American men will die from prostate cancer
- The most common male-specific cancer
- 1 in 8 men will be diagnosed with prostate cancer in his lifetime
Only 25% of men complete the recommended yearly screening
- The PSA screening test for cancer is wrong 80% of the time
- Follow-up tests are unnecessary and extremely invasive
African Americans are 2x more likely to get and die from prostate cancer
Solution (product or service)
We identify unique volatile organic compounds found in urine… Just like Sherlock Holmes’s bloodhound, Toby!
1. Collect urine
2. Perform spectroscopy on urine
3. Predict 'Volatomic Fingerprint'
Every cancer ‘smells’! Specific volatile organic compounds predict cancer
Every cancers ‘smells’ different! Volatile organic compounds predict specific cancers
Patent Pending
Business model
License the technology to reference labs at $50 royalties per test
